CentriMag Circulatory Support System
Abbott · Decision date Oct 30, 2026
What did the FDA decide?
FDA posted a 30-day notice for supplement S034 to PMA P170038 for the CentriMag Circulatory Support System. The stated decision scope is a manufacturing process change to the routine bioburden monitoring program for the CentriMag Blood Pump. The supplement type is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the decision is recorded as OK30.
This notice does not represent a new approval of the entire system or a change in indication. The source statement identifies only the bioburden monitoring program change; it does not describe the specific monitoring method, acceptance criteria, or manufacturing site affected. No safety or effectiveness conclusion is provided in the source fields.
FDA approval order statement
a manufacturing process change to the routine bioburden monitoring program for the CentriMag Blood Pump
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 30, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P170038/S034
- Regulatory pathway
- PMA supplement
- Applicant
- Abbott
- Product code
- DSQ
- Decision code
- OK30
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
For the original device and its historical approval scope, see PMA P170038. Subsequent supplements may change the device or its indications.
FDA decision timeline
P170038 · Original PMA
CentriMag Circulatory Support System
P170038/S032 · Related supplement
CentriMag Circulatory Support System
P170038/S034 received
Application receipt date recorded by FDA.
P170038/S033 · Related supplement
CentriMag Circulatory Support System
P170038/S034 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170038
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott | PMA approval | Dec 6, 2019 | FDA | |
CentriMag Circulatory Support SystemP170038/S032 | Abbott | PMA supplement | Sep 2, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S033 | Abbott | PMA supplement | Oct 2, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
EXCOR Pediatric VADP160035/S056 | Berlin Heart, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 6035 Stoneridge Dr., Pleasanton, CA, 94588
Sources and methodology
- Original FDA record: P170038/S034
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




